These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1896959)

  • 1. Comparative antithrombotic activities of the phosphodiesterase inhibitors pelrinone (AY-26,768), AY-31,390 and milrinone.
    Patelunas DM; Carmint WJ; Willis JZ; Colatsky TJ; Fenichel RL
    Thromb Res; 1991 Jun; 62(5):389-400. PubMed ID: 1896959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic activity of the phosphodiesterase III inhibitor pelrinone in a canine model of coronary artery thrombosis: enhancement of efficacy with concurrent alpha 2-adrenergic antagonism.
    Kitzen JM; McCallum JD; Harvey C; Morin ME
    J Cardiovasc Pharmacol; 1991 Dec; 18(6):777-90. PubMed ID: 1725888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-platelet action of nitric oxide and selective phosphodiesterase inhibitors.
    Sly MK; Eberhart RC; Prager MD
    Shock; 1997 Aug; 8(2):115-8. PubMed ID: 9261901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the effects of three positive inotropic agents (amrinone, milrinone and medorinone) on platelet aggregation in human whole blood.
    Pattison A; Astley N; Eason CT; Bonner FW
    Thromb Res; 1990 Mar; 57(6):909-18. PubMed ID: 2116683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay between milrinone and adenosine in the inhibition of human platelet response.
    Anfossi G; Massucco P; Piretto V; Mularoni E; Cavalot F; Mattiello L; Trovati M
    Gen Pharmacol; 1996 Oct; 27(7):1149-54. PubMed ID: 8981060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of isozyme-selective phosphodiesterase inhibitors on rat aorta and human platelets: smooth muscle tone, platelet aggregation and cAMP levels.
    Lindgren SH; Andersson TL; Vinge E; Andersson KE
    Acta Physiol Scand; 1990 Oct; 140(2):209-19. PubMed ID: 2176433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of plasma adenosine in the antiplatelet action of HL 725, a potent inhibitor of cAMP phosphodiesterase: species differences.
    Agarwal KC; Buckley RS; Parks RE
    Thromb Res; 1987 Jul; 47(2):191-200. PubMed ID: 2821650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potentiation of phosphodiesterase inhibitor antithrombotic activity with alpha-2 adrenergic blockade.
    Kitzen JM; McCallum JD; Pirozzi CT; Colatsky TJ
    Life Sci; 1991; 48(7):PL31-5. PubMed ID: 1671293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of satigrel (E5510), a new anti-platelet drug, in inhibiting human platelet aggregation. Selectivity and potency against prostaglandin H synthases isozyme activities and phosphodiesterase isoform activities.
    Nagakura N; Saeki T; Harada K; Yoshitake S; Kobayashi S; Yamanaka T; Saito I
    Biol Pharm Bull; 1996 Jun; 19(6):828-33. PubMed ID: 8799481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
    Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
    J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the effects of isobutylmethylxanthine and milrinone on ischaemia-induced arrhythmias and platelet aggregation in anaesthetized rabbits.
    Holbrook M; Coker SJ
    Br J Pharmacol; 1989 Sep; 98(1):318-24. PubMed ID: 2478245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of milrinone in human platelet shape change, aggregation and thromboxane A2 synthesis: an in vitro study.
    Barradas MA; Jagroop A; O'Donoghue S; Jeremy JY; Mikhailidis DP
    Thromb Res; 1993 Aug; 71(3):227-36. PubMed ID: 8267765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of milrinone on thromboxane A2 synthesis, cAMP phosphodiesterase and 45Ca2+ uptake by human platelets.
    Jeremy JY; Gill J; Mikhailidis D
    Eur J Pharmacol; 1993 Mar; 245(1):67-73. PubMed ID: 7682964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiplatelet and antithrombotic effects of a novel selective phosphodiesterase 3 inhibitor, NSP-513, in mice and rats.
    Hirose H; Kimura T; Okada M; Itoh Y; Ishida F; Mochizuki N; Nishibe T; Nishikibe M
    Jpn J Pharmacol; 2000 Mar; 82(3):188-98. PubMed ID: 10887949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the effects of cilostazol and milrinone on intracellular cAMP levels and cellular function in platelets and cardiac cells.
    Cone J; Wang S; Tandon N; Fong M; Sun B; Sakurai K; Yoshitake M; Kambayashi J; Liu Y
    J Cardiovasc Pharmacol; 1999 Oct; 34(4):497-504. PubMed ID: 10511123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neferine exerts its antithrombotic effect by inhibiting platelet aggregation and promoting dissociation of platelet aggregates.
    Zhou YJ; Xiang JZ; Yuan H; Liu H; Tang Q; Hao HZ; Yin Z; Wang J; Ming ZY
    Thromb Res; 2013 Aug; 132(2):202-10. PubMed ID: 23773522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of SK&F 95654, a novel phosphodiesterase inhibitor, on cardiovascular, respiratory and platelet function.
    Murray KJ; Eden RJ; Dolan JS; Grimsditch DC; Stutchbury CA; Patel B; Knowles A; Worby A; Lynham JA; Coates WJ
    Br J Pharmacol; 1992 Oct; 107(2):463-70. PubMed ID: 1422592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antithrombotic activity of NSP-513, a novel selective phosphodiesterase 3 inhibitor, on femoral arterial thrombosis induced by physical stenosis and electrical current: comparison of antithrombotic and hemodynamic effects.
    Hirose H; Mashiko S; Kimura T; Ishida F; Mochizuki N; Nishibe T; Nishikibe M
    J Cardiovasc Pharmacol; 2000 Apr; 35(4):586-94. PubMed ID: 10774790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of cyclic nucleotide phosphodiesterase isoenzymes in rat and rabbit ventricular myocardium: positive inotropic and phosphodiesterase inhibitory effects of Org 30029, milrinone and rolipram.
    Shahid M; Nicholson CD
    Naunyn Schmiedebergs Arch Pharmacol; 1990 Dec; 342(6):698-705. PubMed ID: 1710786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disaggregatory effects of prostaglandin E1, amrinone and milrinone on platelet aggregation in human whole blood.
    Kikura M; Kazama T; Ikeda T; Sato S
    Platelets; 2000 Dec; 11(8):446-58. PubMed ID: 11177444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.